Dr. Sameer Husainuddin Nagamia, MD

Dr. Nagamia practices at Florida Medical Clinic Orlando Health Urgent Care in Zephyrhills, Florida.

Dr. Nagamia's NPI, 1528252772, was assigned on August 30, 2007. Dr. Nagamia graduated from Universidad Iberoamericana (UNIBE) in 2000. Dr. Nagamia holds Florida license ME98510.

Dr. Nagamia's primary practice is Florida Medical Clinic Orlando Health Urgent Care, at 38021 Market Square Dr, Zephyrhills, FL 33542. The practice phone is (813) 715-0374.

Dr. Nagamia's primary practice is Florida Medical Clinic Orlando Health Urgent Care in Zephyrhills, Florida. Dr. Nagamia is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is Florida Medical Clinic Orlando Health. Dmand AI also links Dr. Nagamia to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nagamia practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Nagamia's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Nagamia is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Nagamia's licenses on file in 3 states: Florida, Georgia and New York.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Nagamia treats.

CMS data shows 3,407 Medicare services from Dr. Nagamia across 27 procedure codes in 2024, for 847 Medicare patients. Medicare paid $273,269 for them.

CMS counts 847 Medicare patients who saw Dr. Nagamia in 2024. The largest group is 75 to 84, with 335 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nagamia's median patient age at 73, with 52% women.

In 2024, Dr. Nagamia wrote 4,476 Medicare Part D claims for 729 patients. 86% of them were for generic drugs. CMS names the drug for 4,287 of them, across 52 drugs with 11 or more claims each, at $772,313 in total drug cost. In 2023, CMS named 3,447 claims across 43 drugs.

Dr. Nagamia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nagamia as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Nagamia, published from 2007 to 2009. 2007 was the busiest year, with 2. The most frequent topics are Angiotensin-Converting Enzyme Inhibitors, C-Reactive Protein and Double-Blind Method. Dr. Nagamia has published most often in J Clin Lipidol. Dr. Nagamia's most frequent co-author is Anbu V. Pandian, MD.

CMS Open Payments shows 821 general payments to Dr. Nagamia from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. AstraZeneca Pharmaceuticals LP paid the most, $5,205.

Dmand AI lists 1 award for Dr. Nagamia, most recently CMS Stage 1 EHR in 2012.

Dr. Nagamia graduated from Universidad Iberoamericana (UNIBE) in 2000.

Dr. Nagamia is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.